- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
16
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
16 companies
Corcept Therapeutics
Market Cap: US$8.2b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$77.64
7D
2.0%
1Y
148.8%
OS Therapies
Market Cap: US$47.8m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.58
7D
3.3%
1Y
n/a
ARS Pharmaceuticals
Market Cap: US$1.5b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$15.49
7D
6.7%
1Y
73.8%
NRx Pharmaceuticals
Market Cap: US$43.8m
A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.
NRXP
US$2.69
7D
0%
1Y
-26.9%
BioRestorative Therapies
Market Cap: US$13.2m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.75
7D
9.4%
1Y
41.1%
Liquidia
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$15.00
7D
-3.6%
1Y
16.6%
Krystal Biotech
Market Cap: US$3.6b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$125.61
7D
0.3%
1Y
-22.3%
TriSalus Life Sciences
Market Cap: US$179.8m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$5.48
7D
2.4%
1Y
-26.3%
Journey Medical
Market Cap: US$181.8m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$8.07
7D
18.3%
1Y
112.4%
Clene
Market Cap: US$23.7m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$2.74
7D
11.8%
1Y
-59.8%
Protalix BioTherapeutics
Market Cap: US$126.6m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.59
7D
-3.6%
1Y
39.5%
Evaxion
Market Cap: US$16.6m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.30
7D
23.0%
1Y
-87.2%
Harrow
Market Cap: US$951.3m
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$27.20
7D
5.7%
1Y
52.5%
Niagen Bioscience
Market Cap: US$866.7m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.82
7D
6.5%
1Y
282.3%
Bruker
Market Cap: US$5.6b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$37.26
7D
2.5%
1Y
-43.1%
Organogenesis Holdings
Market Cap: US$364.1m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$2.85
7D
-4.0%
1Y
4.4%